Ribosomes unexpectedly variable, powerful
Ribosomes, which make proteins, are startlingly variable in their composition and associations. This variability confers on them the ability to regulate genes, confounding previous ideas, Stanford researchers say.
Surgeon Thomas Nelsen dies at 90
Nelsen contributed to pioneering research in Hodgkin’s lymphoma that helped transform the fatal disease into a curable one.
Heart disease’s link to shingles explained
People with coronary artery disease face an elevated risk for shingles because aberrant immune cells dial down the body’s immune response to viral pathogens, Stanford research shows.
Molecule aids muscle regeneration in mice
Stanford researchers have found that a metabolite stimulates mouse muscle stem cells to proliferate after injury, and anti-inflammatory drugs, frequently taken after exercise, block its production and inhibit muscle repair.
Kenneth Vosti dies at 88
An authority on the causes and management of infectious diseases, Vosti was also known as a committed teacher and administrator, admired for his empathy and warmth.
Mouse lemur as model for human disease
Stanford researchers have identified more than 20 mouse lemurs with genetic traits for conditions such as heart disease and eye problems, making the tiny primates potentially useful for understanding diseases in humans.
Deisseroth wins Fresenius Prize
The Stanford psychiatrist, neuroscientist and bioengineer will be honored for three distinct contributions to the medical field: optogenetics, hydrogel-tissue chemistry and research into depression.
Data sifting finds hidden gene partnerships
Targeting backup biological pathways often used by cancers can lead to more efficient drug development and less-toxic therapies. Stanford researchers have developed a new way to identify these pathways.
Psoriatic arthritis drug shows promise
In a randomized clinical trial conducted by researchers at Stanford and more than 100 other medical centers, psoriatic arthritis patients given an injectable biologic drug for 24 weeks showed substantial improvement compared with patients who received placebo injections.
Preventing HIV among drug users
As more people inject drugs like heroin, the risk of an HIV outbreak from shared needles increases. Stanford researchers examined four methods that could be cost-effective in preventing an outbreak.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.